首页 >
法规速递
-
Document: HMPC meeting report on European Union herbal monographs, guidelines and other activities - 22-24 September 2025-2025/10/10
2025-10-11查看详情 > -
Page: Emergency Task Force (ETF) recommendations-2025/11/17
2025-11-18查看详情 > -
Document: Work plan for the Committee for Veterinary Medicinal Products (CVMP) Immunologicals Working Party (IWP) 2026-2025/12/12
2025-12-15查看详情 > -
Document: European Medicines Agency’s data protection notice for the EudraVigilance Signal and Safety Analytics (EV SSA) platform-2026/1/26
2026-01-27查看详情 > -
Document: Darwin EU: How often respiratory syncytial virus (RSV) affects different age groups in Europe-2026/3/4
2026-03-05查看详情 > -
Incorporating Voluntary Patient Preference Information over the Total Product Life Cycle-2026/3/30
2026-04-02查看详情 > -
Opioid Analgesic Drugs: Considerations for Benefit-Risk Assessment Framework-2026/5/13
2026-05-15查看详情 > -
Scientific guideline: Reflection paper on the criteria to be considered for the evaluation of new active substance (NAS) status of biological substances-2022/11/18
2022-11-30查看详情 > -
国家药品监督管理局批准硫酸氢司美替尼胶囊上市-2023/6/1
2023-06-01查看详情 > -
国家药监局药审中心关于发布《特应性皮炎治疗药物临床试验技术指导原则》的通告(2023年第58号)-2023/12/1
2023-12-04查看详情 >